Migraine and CVD Risk in Women

NAActive, not recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 1, 2017

Primary Completion Date

June 30, 2020

Study Completion Date

June 30, 2026

Conditions
Migraine
Interventions
OTHER

Mixed meal tolerance testing

An intravenous catheter is placed for serial blood draws for inflammatory markers and ancillary studies. The participant consumes a test meal, and measurements are made for 4 hours.

OTHER

Skin conductance & cold pressor test

Skin conductance will be monitored continuously with 2 electrodes placed on the plantar surface of the foot. To induce pain, we will use the cold pressor test. Participants submerge one hand in a bath with iced water (2-4ºC) for 2 minutes. Blood pressure and heart rate are monitored every minute starting 5 minutes before the cold pressor test and for 10 minutes after the participant withdraws the hand from the bath. This testing will be performed at baseline and post-meal.

OTHER

Flow-mediated dilation testing

At baseline and post-meal, we will assess flow-mediated dilation at the brachial artery using well-validated ultrasound techniques.

Trial Locations (2)

19004

University of Pennsylvania, Philadelphia

19104

Children's Hospital of Philadelphia, Philadelphia

All Listed Sponsors
lead

University of Pennsylvania

OTHER

NCT03081390 - Migraine and CVD Risk in Women | Biotech Hunter | Biotech Hunter